| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |